Skip to main content
. 2017 Jul 5;8(59):100801–100818. doi: 10.18632/oncotarget.19007

Table 4. Comparison of EGFR T790M detection platforms in tissue.

S.No Method Sample EGFR T790M Detection rate % Study group
Treatment Naive/Pre-treatment Post-TKI
1 Scorpion ARMS Tissue N = 29 0 48.3 Chen HJ et al. [84]
2 Direct sequencing Tissue N = 14 0 50 Kosaka et al. [75]
3 ARMS Tissue N = 10 - 0 Zhang et al. [85]
ddPCR - 50
4 Standard HRM Tissue N = 146 0 - Hashida et al. [107]
MEC-HRM 13 -
5 SABER Tissue N = 28 7 - Sakai et al.[120]
6 Ion Torrent PGM NGS Tissue N = 15 - 60 Masago et al. [94]
7 ddPCR Tissue N = 12 83.3 - Isobe K et al. [92]
8 MALDI-TOF MS Tissue N = 54 7.1 - Su K.Y et al. [97]
NGS 14.3 -
9 PNA-clamping PCR Tissue N = 50 - 68 Costa C et al. [110]
10 ddPCR Tissue N = 78 6.4 - Xu et al. [93]
11 ACB-ARMS PCR Tissue N = 27 22.2 - Zhao J et al. [83]
12 PNA-clamping PCR Tissue N = 147 8.2 - Oh et al. [76]
Direct sequencing 0 -
13 ddPCR Tissue N = 373 79.9 - Watanabe M et al.[105]
14 Direct sequencing Tissue + other clinical samples N = 280 0.3 1.05 Inukai M et al. [77]
Mutant-enriched PCR 3.5 3.1
15 TaqMan PCR Tissue N = 129 35 - Rosell R et al. [122]
16 SARMS Tissue N = 38 0 - Fujita Y et al. [86]
Colony hybridisation 79 -
17 Direct sequencing Tissue N = 98 2 - Sequist LV et al. [71]
18 Direct sequencing Tissue+other clinical samples N = 1261 0.5 - Wu JY et al. [79]
19 NGS
(Miseq/Hiseq2000/Hiseq2500)
Tissue N = 209 0.48 - Hagemann IS et al.[108]
20 LNA-PCR sequencing Tissue N = 155 - 62 Yu HA et al. [111]
21 Direct sequencing Tissue+other clinical samples N = 69 - 49 Arcila ME et al. [80]
RFLP-PCR Tissue+other clinical samples N = 45 - 53
LNA-PCR sequencing Tissue+other clinical samples N = 64 - 70
22 TaqMan PCR Tissue+other clinical samples N = 15 - 40 Molina-Vila MA et al. [123]
23 AMRS Tissue N = 609 0.8 - Mok TS et al. [87]
24 Direct sequencing Tissue N = 74 - 1.35 Soh J et al. [81]
25 Cobas(Roche)/ARMS (Qiagen) Tissue N = 148 - 53 Sequist LV et al. [101]
26 Cobas (Roche) Tissue N = 222 - 62 Janne PA et al. [21]
27 ARMS Tissue N = 134 6.8 28.4 Yu J et al. [124]
28 NGS (MiSeq) Tissue = 15 - 73.3 Paweletz et al. [95]
29 NGS (AmpliSeq cancer hotspot panel v2) Tissue N = 43 - 79 Belchis DA et al. [96]

‘-‘: not reported